Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Minority Interest (2016 - 2025)

Historic Minority Interest for Metlife (MET-PF) over the last 17 years, with Q3 2025 value amounting to $247.0 million.

  • Metlife's Minority Interest fell 1146.95% to $247.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.0 million, marking a year-over-year decrease of 1146.95%. This contributed to the annual value of $258.0 million for FY2024, which is 840.34% up from last year.
  • As of Q3 2025, Metlife's Minority Interest stood at $247.0 million, which was down 1146.95% from $242.0 million recorded in Q2 2025.
  • In the past 5 years, Metlife's Minority Interest registered a high of $288.0 million during Q2 2024, and its lowest value of $229.0 million during Q1 2023.
  • In the last 5 years, Metlife's Minority Interest had a median value of $261.0 million in 2024 and averaged $258.7 million.
  • As far as peak fluctuations go, Metlife's Minority Interest surged by 2467.53% in 2024, and later plummeted by 1597.22% in 2025.
  • Quarter analysis of 5 years shows Metlife's Minority Interest stood at $267.0 million in 2021, then decreased by 8.61% to $244.0 million in 2022, then dropped by 2.46% to $238.0 million in 2023, then grew by 8.4% to $258.0 million in 2024, then fell by 4.26% to $247.0 million in 2025.
  • Its last three reported values are $247.0 million in Q3 2025, $242.0 million for Q2 2025, and $262.0 million during Q1 2025.